184 related articles for article (PubMed ID: 11412475)
1. [Pleurodesis with tetracyclines after fontan operation].
Torres Borrego J; Nieves Martínez Gil C; Pérez Ruiz E; Pérez Frías J; Martínez Valverde A
An Esp Pediatr; 2001 Jul; 55(1):76-9. PubMed ID: 11412475
[TBL] [Abstract][Full Text] [Related]
2. Successful bleomycin pleurodesis in a patient with prolonged pleural effusion after extracardiac fontan procedure.
Tansel T; Sayin OA; Ugurlucan M; Dayioglu E; Onursal E
J Card Surg; 2006; 21(6):585-6. PubMed ID: 17073958
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for persistent pleural effusions after the extracardiac Fontan procedure.
Gupta A; Daggett C; Behera S; Ferraro M; Wells W; Starnes V
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1664-9. PubMed ID: 15173721
[TBL] [Abstract][Full Text] [Related]
4. [Management of malignant pleural effusion by tetracycline pleurodesis].
Horváth T; Orosz E; Czenkár B
Orv Hetil; 1989 May; 130(20):1051-2. PubMed ID: 2471952
[TBL] [Abstract][Full Text] [Related]
5. Prolonged pleural effusion following Fontan operation: effective pleurodesis with talc slurry.
Kiziltepe U; Eyileten ZB; Uysalel A; Akalin H
Int J Cardiol; 2002 Oct; 85(2-3):297-299. PubMed ID: 12208597
[TBL] [Abstract][Full Text] [Related]
6. Factors related to pleural effusions after Fontan procedure in the era of fenestration.
Fedderly RT; Whitstone BN; Frisbee SJ; Tweddell JS; Litwin SB
Circulation; 2001 Sep; 104(12 Suppl 1):I148-51. PubMed ID: 11568047
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary vascular compliance and pleural effusion duration after the Fontan procedure.
Yun TJ; Im YM; Jung SH; Jhang WK; Park JJ; Seo DM; Kim YH; Park IS; Ko JK; Lee MS
Int J Cardiol; 2009 Mar; 133(1):55-61. PubMed ID: 18243371
[TBL] [Abstract][Full Text] [Related]
8. Pleural effusions following the Fontan procedure.
Mascio CE; Austin EH
Curr Opin Pulm Med; 2010 Jul; 16(4):362-6. PubMed ID: 20410822
[TBL] [Abstract][Full Text] [Related]
9. Reduced pleural drainage, length of stay, and readmissions using a modified Fontan management protocol.
Pike NA; Okuhara CA; Toyama J; Gross BP; Wells WJ; Starnes VA
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):481-7. PubMed ID: 26254747
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion.
Balassoulis G; Sichletidis L; Spyratos D; Chloros D; Zarogoulidis K; Kontakiotis T; Bagalas V; Porpodis K; Manika K; Patakas D
Am J Clin Oncol; 2008 Aug; 31(4):384-9. PubMed ID: 18845999
[TBL] [Abstract][Full Text] [Related]
11. Protein-losing enteropathy after Fontan operation: resolution after baffle fenestration.
Jacobs ML; Rychik J; Byrum CJ; Norwood WI
Ann Thorac Surg; 1996 Jan; 61(1):206-8. PubMed ID: 8561554
[TBL] [Abstract][Full Text] [Related]
12. A medical strategy to reduce persistent chest tube drainage after the fontan operation.
Cava JR; Bevandic SM; Steltzer MM; Tweddell JS
Am J Cardiol; 2005 Jul; 96(1):130-3. PubMed ID: 15979451
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature.
Breuer GS; Deeb M; Fisher D; Nesher G
Semin Arthritis Rheum; 2005 Apr; 34(5):744-9. PubMed ID: 15846590
[TBL] [Abstract][Full Text] [Related]
14. [Pleurodesis as a palliative method in the treatment of pleural effusions of malignant etiology].
Sikimić S; Dangubić V
Plucne Bolesti; 1988; 40(1-2):13-7. PubMed ID: 2460882
[No Abstract] [Full Text] [Related]
15. [Therapeutic pleurodesis in spontaneous pneumothorax, malignant pleural effusion, heart insufficiency and chylothorax].
Storm HK; Viskum K
Ugeskr Laeger; 1991 Apr; 153(14):989-92. PubMed ID: 2024319
[TBL] [Abstract][Full Text] [Related]
16. Plastic bronchitis: is thoracic duct ligation a real surgical option?
Shah SS; Drinkwater DC; Christian KG
Ann Thorac Surg; 2006 Jun; 81(6):2281-3. PubMed ID: 16731170
[TBL] [Abstract][Full Text] [Related]
17. Does the off-pump Fontan procedure ameliorate the volume and duration of pleural and peritoneal effusions?
Shikata F; Yagihara T; Kagisaki K; Hagino I; Shiraishi S; Kobayashi J; Kitamura S
Eur J Cardiothorac Surg; 2008 Sep; 34(3):570-5; discussion 575. PubMed ID: 18640049
[TBL] [Abstract][Full Text] [Related]
18. Recurrent pleural effusion: who benefits from a tunneled pleural catheter?
Schneider T; Reimer P; Storz K; Klopp M; Pfannschmidt J; Dienemann H; Hoffmann H
Thorac Cardiovasc Surg; 2009 Feb; 57(1):42-6. PubMed ID: 19169996
[TBL] [Abstract][Full Text] [Related]
19. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions.
Akopov AL; Egorov VI; Varlamov VV; Levashev YN; Artioukh DY
Eur J Cardiothorac Surg; 2005 Nov; 28(5):750-3. PubMed ID: 16198593
[TBL] [Abstract][Full Text] [Related]
20. The technique of pleurodesis.
Elpern EH; Krueger J; Kimsey J; Silver M
J Crit Illn; 1994 Dec; 9(12):1105-10. PubMed ID: 10150700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
